Methylation of dual-specificity phosphatase 4 controls cell differentiation is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 1.1. It has been cited 34 times, with 23 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
0.557
From 21 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 23 citers.
National Institutes of Health
Grant: 1R21CA202390
National Institutes of Health
Grant: 1R01DK110574
National Cancer Institute
Grant: 5P30 CA008748
Department of Veterans Affairs
Grant: BX004426
Department of Veterans Affairs
Grant: BX0003617
Eli Lilly and Company
Grant: ARRY614
Eli Lilly and Company
Grant: NCT01496495
NCI NIH HHS
Grant: R21 CA202390
NIGMS NIH HHS
Grant: R01 GM122749
NIGMS NIH HHS
Grant: R35 GM131858
NCI NIH HHS
Grant: T32 CA062948
NIGMS NIH HHS
Grant: R01 GM126154
BLRD VA
Grant: I01 BX004426
BLRD VA
Grant: IK6 BX003617
NCI NIH HHS
Grant: P30 CA008748
BLRD VA
Grant: IK6 BX005800
NIDDK NIH HHS
Grant: R01 DK110574
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01GM126154-02
Mechanism and Inhibition of Protein Arginine Methylation
National Institutes of Health
Grant: 5R01GM122749-03
Discovery of Selective Inhibitors for Histone Methyltransferases
National Institutes of Health
Grant: 5R35GM131858-02
Interrogating Protein Methyltransferases with Integrated Approaches
National Institutes of Health
Grant: 1R01DK110574-01A1
The Functions of antisense RNA AS-RBM15 in hematopoiesis
National Institutes of Health
Grant: 5R21CA202390-02
PRMT1-mediated metabolic reprogramming in leukemia progression
Elsa U. Pardee Foundation
GlaxoSmithKline
New York University
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study
Additional file 1 of Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study